RNTX
Rein Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:11:46 PM EST
0.38USD+7.716%(+0.03)1,059,987
Pre-marketNov 19, 2026 9:17:30 AM EST
0.3625USD+2.837%(+0.01)
Loading…
Loading…
32.48M
Previous Close
$0.36
Beta
2.29
52-Week High
$2.10 2026-04-22
52-Week Low
$0.28 2026-11-16
SMA 50
$0.68
SMA 200
$0.99
Avg. Vol 10D
1.45M
Avg. Vol 30D
756,480
Avg. Vol 90D
540,296
Relative Vol
1.39
86.27M
66.11M
76.63%
706,730
1.07%
2.10
29%/71%
60.46%
44.34%
2.4500%
6,300,000
28,700
28,700
28,700
-49.7M
-0.92
-100.48
Nov 18, 2026
Nov 17, 2026
Rein reports early Phase II data for inhaled IPF drug ·
Clinical Trials Arena
Nov 16, 2026
Aileron Therapeutics reports Q3 results ·
Seeking Alpha
RNTX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.56 | 2026-11-12 | -32.77% | 16.824 |
| 1M | 0.55 | 2026-10-19 | -31.79% | 3.408 |
| 3M | 0.79 | 2026-08-19 | -52.46% | 3.737 |
| 6M | 1.00 | 2026-05-19 | -62.16% | 2.876 |
| 1Y | 1.26 | 2025-11-19 | -70.12% | 2.290 |
| 2Y | 1.93 | 2025-01-13 | -80.49% | — |
RNTX Stock Summary
Rein Therapeutics, Inc. Common Stock (NASDAQ:RNTX) stock price today is $0.38, and today's volume is 1,054,933. RNTX is up 5.967% today. The 30 day average volume is 756,480. RNTX market cap is $32.48M with 86.27M shares outstanding.